Remission in cancer means the signs and symptoms of your disease have decreased or disappeared after treatment. It does not necessarily mean the cancer is gone forever. Doctors classify remission into two categories, partial and complete, based on how much the cancer has shrunk and whether it can still be detected.
Partial vs. Complete Remission
Partial remission means imaging scans and blood tests show your tumors have shrunk by at least 50% compared to before treatment, and the remaining cancer cells don’t appear to be growing. For blood cancers like leukemia or lymphoma, partial remission means significantly fewer cancerous cells are circulating in your blood.
Complete remission is a step further: no evidence of cancer can be found on physical exams, blood work, or imaging tests. You may also hear your doctor use the phrase “no evidence of disease,” or NED. This term means exactly what it sounds like, but it comes with an important caveat. No evidence of disease on a scan is not the same as confirmed disease clearance. Cancer cells can exist at levels too small for current tests to detect.
Why Remission Isn’t the Same as a Cure
A cure means cancer is completely gone and will never return. Remission is more cautious. It describes what doctors can observe right now: that the cancer isn’t detectable or has significantly shrunk. The distinction matters because microscopic cancer cells can remain in your body for years after treatment and potentially grow back.
The five-year mark carries special significance. If you remain in complete remission for five years or more, some doctors will use the word “cured.” This threshold exists because most cancers that return do so within the first five years after treatment. But “most” isn’t “all,” and the timeline varies by cancer type.
How Recurrence Patterns Vary by Cancer Type
Not all cancers follow the same clock when it comes to recurrence risk. In a large breast cancer study tracking patients over a median of five years, about 12% experienced a recurrence. But the timing depended heavily on the biology of the tumor.
Hormone receptor-negative breast cancers tend to recur early, usually within three years. If they haven’t come back by then, subsequent recurrence is rare. Hormone receptor-positive breast cancers behave differently. Their recurrence risk is lower year to year but persists steadily over a longer period, sometimes well beyond the five-year window. This is one reason some people stay on preventive medication for a decade or more.
Other cancers have their own patterns. Some, like certain skin cancers caught early, have very high cure rates. Others, like pancreatic or advanced lung cancers, carry higher recurrence risks even after initially successful treatment.
Maintenance Therapy During Remission
For some cancers, treatment doesn’t stop when remission begins. Maintenance therapy is a less intensive, lower-toxicity treatment designed to keep the cancer from coming back. There are two main approaches: continuing a gentler version of the same treatment that achieved remission, or switching to a different, better-tolerated medication.
The evidence for maintenance therapy is compelling in certain cancers. In one trial involving advanced soft tissue sarcoma, patients who continued treatment after their cancer was controlled had a six-month progression-free rate of about 52%, compared to 23% for those who stopped treatment. Another study found that maintenance treatment doubled the time before cancer progressed (12 months vs. 6 months) and extended overall survival by roughly nine months. The tradeoff is that staying on treatment longer can increase side effects like bone marrow suppression, so doctors try to find the balance between keeping cancer at bay and preserving quality of life.
What Monitoring Looks Like
Once you’re in remission, regular follow-up appointments become the new rhythm of your care. In general, you’ll see your oncologist every three to four months for the first two to three years, then once or twice a year after that. These visits typically include a physical exam, blood tests, and sometimes imaging scans, depending on your cancer type and your doctor’s judgment.
The goal is to catch any recurrence as early as possible. Your follow-up schedule will be tailored to your specific situation. Someone who had an aggressive cancer that’s now in complete remission will likely be monitored more closely than someone who had an early-stage cancer with a very high cure rate. The National Comprehensive Cancer Network updated its survivorship guidelines in 2025, emphasizing not just surveillance but also physical activity, nutrition, and overall wellness as part of post-treatment care.
Lifestyle Factors That Reduce Recurrence Risk
What you do during remission can meaningfully affect your odds of staying there. Physical activity has the strongest evidence of any lifestyle factor for reducing cancer recurrence. A meta-analysis of 22 studies found that women who exercised regularly after a breast cancer diagnosis reduced their breast cancer mortality by about 40%. The recommended target: at least 30 minutes of moderate exercise five days a week, or 75 minutes of vigorous exercise, plus two to three strength training sessions.
Diet plays a role too, though the evidence is more nuanced. In the Women’s Intervention Nutrition Study, participants who reduced their dietary fat intake by about 15% had a lower incidence of disease recurrence. High intake of full-fat dairy (more than one serving daily) was linked to worse outcomes, while low-fat dairy showed no such association. Soy, despite persistent myths about it being harmful, appears to be protective. A meta-analysis across U.S. and Chinese studies found that higher soy consumption after diagnosis was associated with a 26% decrease in recurrence and a 16% reduction in breast cancer death.
Interestingly, studies comparing a “prudent” diet rich in fruits, vegetables, whole grains, and chicken to a typical Western diet high in processed meats and refined grains found equivalent recurrence rates. This suggests that specific dietary components matter more than broad dietary patterns, and that exercise remains the most reliable lifestyle lever you can pull.
Spontaneous Remission
In rare cases, cancer regresses without any treatment at all. Spontaneous remission has been documented across virtually every type of human cancer, though it occurs most often in neuroblastoma, kidney cancer, melanoma, and blood cancers. The mechanisms aren’t fully understood, but researchers believe the immune system plays a central role, possibly recognizing and attacking cancer cells after some triggering event. Other proposed explanations include hormonal shifts, loss of blood supply to the tumor, and programmed cell death kicking in belatedly. In some cases, multiple mechanisms likely work together. Spontaneous remission remains genuinely rare and unpredictable, so it’s not something treatment decisions are built around.